MARKET

ZYME

ZYME

Zymeworks
NASDAQ
30.81
+1.18
+3.98%
After Hours: 31.10 +0.29 +0.94% 18:28 11/09 EST
OPEN
30.00
PREV CLOSE
29.63
HIGH
30.88
LOW
29.66
VOLUME
1.16M
TURNOVER
--
52 WEEK HIGH
31.49
52 WEEK LOW
16.57
MARKET CAP
2.17B
P/E (TTM)
-15.2987
1D
5D
1M
3M
1Y
5Y
1D
Zymeworks Reports Quarterly Results, Raises 2026 Guidance
TipRanks · 5h ago
*Zymeworks 3Q Net $173.7M >ZYME
Dow Jones · 7h ago
Press Release: Zymeworks Provides Corporate -2-
Dow Jones · 7h ago
Weekly Report: what happened at ZYME last week (1102-1106)?
Weekly Report · 18h ago
Zymeworks Can No Longer Hide Behind Its Partners' Milestones
Barchart · 3d ago
Zymeworks (ZYME) Stock Seems Fully Priced On Its 336% Run
Simply Wall St · 4d ago
Is Zymeworks (ZYME) A Bargain On New ZW191 Data And The Roche Deal?
Simply Wall St · 5d ago
Learn Why The Bull Case For Zymeworks Stock Could Change Following Phase 1 Ovarian Cancer Data
Simply Wall St · 11/03 00:35
More
About ZYME
Zymeworks Inc. is a global biotechnology company building a diversified portfolio of healthcare assets. The Company's asset and royalty aggregation strategy combines a portfolio of commercial and near-commercial assets, including YUPELRI (revefenacin), with a differentiated internal research and development engine. The Company's portfolio also includes Ziihera (zanidatamab-hrii), a HER2-targeted bispecific antibody discovered and developed by it and commercialized through global partnerships with Jazz Pharmaceuticals and BeOne Medicines, and pasritamig, a clinical-stage multispecific antibody developed by Johnson & Johnson using the Company's proprietary antibody engineering technologies. The Company is advancing a diverse pipeline of novel biotherapeutics, leveraging its proprietary Azymetric platform and expertise in antibody-drug conjugates, multispecific antibodies and other next-generation antibody technologies. Its product candidates include ZW191, ZW251, ZW220, ZW209 and ZW1528.

Webull offers Zymeworks Inc stock information, including NASDAQ: ZYME real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ZYME stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ZYME stock methods without spending real money on the virtual paper trading platform.